Home pageSTAR • NSE
add
Strides Pharma Science Ltd
Chiusura precedente
1.643,30 ₹
Intervallo giornaliero
1.593,55 ₹ - 1.654,95 ₹
Intervallo annuale
467,00 ₹ - 1.675,00 ₹
Cap di mercato
149,79 Mrd INR
Volume medio
349.474,00
Rapporto P/E
3.343,12
Dividendo/Prezzo
0,15%
Borsa valori principale
NSE
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
(INR) | giu 2024info | Variazione Y/Y |
---|---|---|
Entrate | 10,88 Mrd | 16,94% |
Spese di gestione | 4,99 Mrd | 13,84% |
Utile netto | 702,02 Mln | 1.086,95% |
Margine di profitto netto | 6,46 | 950,00% |
Utili per azione | — | — |
EBITDA | 2,24 Mrd | 33,22% |
Aliquota fiscale effettiva | 19,80% | — |
Stato patrimoniale
Totale attivo
Totale passivo
(INR) | giu 2024info | Variazione Y/Y |
---|---|---|
Investimenti cash/breve termine | 2,97 Mrd | -19,05% |
Totale attivo | — | — |
Totale passivo | — | — |
Patrimonio netto totale | 20,72 Mrd | — |
Azioni in circolazione | 91,89 Mln | — |
Prezzo/valore contabile | 7,10 | — |
Redditività dell'attivo | — | — |
Rendimento sul capitale | 9,17% | — |
Flusso di cassa
Flusso di cassa netto
(INR) | giu 2024info | Variazione Y/Y |
---|---|---|
Utile netto | 702,02 Mln | 1.086,95% |
Liquidità di esercizio | — | — |
Contanti da investimenti | — | — |
Contanti da finanziamenti | — | — |
Flusso di cassa netto | — | — |
Flusso di cassa libero | — | — |
Informazioni
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
Fondazione
1990
Sito web
Dipendenti
3.065